Molecular cytogenetic analysis of gene rearrangements in childhood acute lymphoblastic leukemia

scientific article

Molecular cytogenetic analysis of gene rearrangements in childhood acute lymphoblastic leukemia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3346/JKMS.2005.20.1.36
P932PMC publication ID2808572
P698PubMed publication ID15716599
P5875ResearchGate publication ID8015938

P50authorHee-Yeon WooQ96352616
Hyosoon ParkQ96352618
P2093author name stringHong Hoe Koo
Dae Won Kim
Sun Hee Kim
Ki Woong Seong
P2860cites workChromosome 21 abnormalities with AML1 amplification in acute lymphoblastic leukemiaQ33182473
Cytogenetics and molecular genetics of childhood leukemiaQ33820790
The TEL-AML1 fusion accompanied by loss of the untranslocated TEL allele in B-precursor acute lymphoblastic leukaemia of childhoodQ34293528
AML1 amplification in a child with acute lymphoblastic leukemiaQ35054383
High frequency of chromosome 9 deletion in ovarian cancer: evidence for three tumour-suppressor loci.Q36135042
Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero.Q38467837
Trisomy 21 is a recurrent secondary aberration in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusionQ38499377
Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cellsQ40854057
TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell linesQ42811971
Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma.Q42814171
ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphocytic leukemiaQ47332078
The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemiaQ47335313
Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group study.Q50974534
Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-MünQ52999147
Low incidence of TEL/AML1 fusion and TEL deletion in Korean childhood acute leukemia by extra-signal fluorescence in situ hybridizationQ57215788
Spectral karyotyping and interphase FISH reveal abnormalities not detected by conventional G-banding. Implications for treatment stratification of childhood acute lymphoblastic leukaemia: detailed analysis of 70 casesQ58861981
Interphase fluorescence in situ hybridization and spectral karyotyping reveals hidden genetic aberrations in children with acute lymphoblastic leukaemia and a normal banded karyotypeQ58861998
TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemiaQ71834799
Do terminal deletions of 11q23 exist? Identification of undetected translocations with fluorescence in situ hybridizationQ72100930
Low frequency of the TEL/AML1 fusion gene in acute lymphoblastic leukaemia in SpainQ73231169
Homozygous deletion of the p16/MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcomeQ73374179
Hemizygous p16(INK4A) deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapseQ73387939
Amplification of AML1 in childhood acute lymphoblastic leukemiasQ73593490
AML1 gene amplification: a novel finding in childhood acute lymphoblastic leukemiaQ73651964
TEL/AML1 transcript and p16 gene deletion in a patient with childhood acute lymphoblastic leukaemiaQ73851114
Cytogenetic and FISH studies of a single center consecutive series of 152 childhood acute lymphoblastic leukemiasQ74068223
Characterization of additional genetic events in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion: a molecular cytogenetics studyQ74408884
Hematological malignancies with a deletion of 11q23: cytogenetic and clinical aspects. European 11q23 Workshop participantsQ74566325
Comparative incidence of the rearrangements of TEL/AML1 and ALL1 genes in pediatric precursor B acute lymphoblastic leukemias in IndiaQ77587265
Cytogenetic abnormalities associated with the t(12;21): a collaborative study of 169 children with t(12;21)-positive acute lymphoblastic leukemiaQ78247889
Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: A report from the Children's Cancer GroupQ93926206
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P433issue1
P921main subjectleukemiaQ29496
lymphoblastic leukemiaQ18553852
P304page(s)36-41
P577publication date2005-02-01
P1433published inJournal of Korean Medical ScienceQ24039955
P1476titleMolecular cytogenetic analysis of gene rearrangements in childhood acute lymphoblastic leukemia
P478volume20

Reverse relations

cites work (P2860)
Q37661998A comparison of acute lymphoblastic leukemia in Down syndrome and non-Down syndrome children: the role of trisomy 21.
Q46273869Cytogenetic analysis in childhood acute lymphoblastic leukemia: experience at a single institution in Korea
Q36679548Evaluation of ETV6/RUNX1 Fusion and Additional Abnormalities Involving ETV6 and/or RUNX1 Genes Using FISH Technique in Patients with Childhood Acute Lymphoblastic Leukemia
Q41490108High frequency and poor prognosis of late childhood BCR-ABL-positive and MLL-AF4-positive ALL define the need for advanced molecular diagnostics and improved therapeutic strategies in pediatric B-ALL in Pakistan.
Q58861769Interphase fluorescent in situ hybridization deletion analysis of the 9p21 region and prognosis in childhood acute lymphoblastic leukaemia (ALL): results from a prospective analysis of 519 Nordic patients treated according to the NOPHO-ALL 2000 proto
Q53425233Native ETV6 deletions accompanied by ETV6-RUNX1 rearrangements are associated with a favourable prognosis in childhood acute lymphoblastic leukaemia: a candidate for prognostic marker.
Q54434736Sequential monitoring of minimal residual disease in acute lymphoblastic leukemia: 7-year experience in a pediatric hematology/oncology unit.

Search more.